Correction to: Comprehensive genomic profiling on metastatic Melanoma: results from a network screening from 7 Italian Cancer Centres

• Matteo Pallocca,
• Ivan Molineris,
• Enrico Berrino,
• Benedetta Marcozzi,
• Martina Betti,
• Lauretta Levati,
• Stefania D’Atri,
• Chiara Menin,
• Gabriele Madonna,
• Paola Ghiorzo,
• Jenny Bulgarelli,
• Virgina Ferraresi,
• Tiziana Venesio,
• Monica Rodolfo,
• Licia Rivoltini,
• Luisa Lanfrancone,
• Paolo Antonio Ascierto,
• Luca Mazzarella,
• Pier Giuseppe Pelicci,
• Ruggero De Maria,
• Gennaro Ciliberto,
• Enzo Medico,
• Giandomenico Russo

Affiliations

Matteo Pallocca

Institute of Experimental Endocrinology and Oncology, National Research Council

Ivan Molineris

Department of Life Science and System Biology, University of Turin

Enrico Berrino

Candiolo Cancer Institute, FPO-IRCCS

Benedetta Marcozzi

Biostatistics, Bioinformatics and Clinical Trial Center, IRCCS Regina Elena National Cancer Institute

Martina Betti

Biostatistics, Bioinformatics and Clinical Trial Center, IRCCS Regina Elena National Cancer Institute

Lauretta Levati

Laboratory of Molecular Oncology, IDI-IRCCS

Stefania D’Atri

Laboratory of Molecular Oncology, IDI-IRCCS

Chiara Menin

Immunology and Oncological Molecular Diagnostics, Oncological Institute, IOV IRCCS UOC

Gabriele Madonna

Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale

Paola Ghiorzo

Genetics of Rare Cancers, IRCCS Ospedale Policlinico San Martino

Jenny Bulgarelli

Immunotherapy, Cell Therapy and Biobank Unit, IRCCS Istituto Romagnolo Per lo Studio dei Tumori (IRST) “Dino Amadori”

Virgina Ferraresi

Sarcoma and Rare Tumours Departmental Unit- IRCCS Regina Elena National Cancer Institute-Rome

Tiziana Venesio

Candiolo Cancer Institute, FPO-IRCCS

Monica Rodolfo

Unit of Translational Immunology, Department of Experimental Oncology, IRCCS Foundation National Cancer Institute

Licia Rivoltini

Unit of Translational Immunology, Department of Experimental Oncology, IRCCS Foundation National Cancer Institute

Luisa Lanfrancone

Department of Experimental Oncology, European Institute of Oncology IRCCS (IEO)

Paolo Antonio Ascierto

Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale

Luca Mazzarella

Department of Experimental Oncology, European Institute of Oncology IRCCS (IEO)

Pier Giuseppe Pelicci

Department of Experimental Oncology, European Institute of Oncology IRCCS (IEO)

Ruggero De Maria

Institute of General Pathology, Catholic University “Sacro Cuore”

Gennaro Ciliberto

Scientific Direction, IRCCS Regina Elena National Cancer Institute

Enzo Medico

Candiolo Cancer Institute, FPO-IRCCS

Giandomenico Russo

Istituto Dermopatico dell’Immacolata, IDI-IRCCS